CDKN1A and non-small cell lung carcinoma: Inhibiting p21 function could prevent NSCLC cells from entering, or push cells out of, p21-dependent quiescence, where they would be susceptible to treatment with chemotherapy, in a 'kick and kill' approach, akin to the strategy used in HIV to eliminate latently infected cells [49, 50].